Shin Miyamura

This inventor holds 20 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Compounds. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2007-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shin Miyamura. Retrieved from https://idiyas.com/inventor/shin-miyamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 10)

% Patents Active = 40.0

CIPO Patents = 3

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 11.9

ph-index = 5

Forward Citations = 93(Granted Patents)

Location History:

Matsushige, JP (2007 - 2012)
Osaka, JP (2014 - 2017)
Tokushima, JP (2011 - 2020)

Company Filing History:

20 out of 846

Otsuka Pharmaceutical Company, Limited

patents

Years Active: 2007-2020

Loading Chart...

Areas of Expertise:

Piperazine

Benzothiophenes

Mental Disorders

Monoamines Reuptake Inhibitors

Vasopressin Antagonists

CNS Disorders

Therapeutic Compounds

4-Piperazin-1-yl

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE48059 - Piperazine-substituted benzothiophenes for treatment of mental disorders (2020-06-22),

2. 10000450 - N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors (2018-06-19),

3. 9839637 - Piperazine-substituted benzothiophenes for treatment of mental disorders (2017-12-12),

4. 9630947 - Therapeutic compounds and related methods of use (2017-04-25),

5. 9611214 - N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors (2017-04-04),

6. 9480686 - Piperazine-substituted benzothiophenes for treatment of mental disorders (2016-11-01),

7. 9206167 - Piperazine-substituted benzothiophenes for treatment of mental disorders (2015-12-08),

8. 9073890 - Therapeutic compounds and related methods of use (2015-07-07),

9. 9073868 - Benzazepine derivatives useful as vasopressin antagonists (2015-07-07),

10. 8815871 - N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors (2014-08-26),

11. 8785386 - Benzazepine derivatives useful as vasopressin antagonists (2014-07-22),

12. 8669229 - Benzazepine derivatives useful as vasopressin antagonists (2014-03-11),

13. 8618109 - Piperazine-substituted benzothiophenes for treatment of mental disorders (2013-12-31),

14. 8420623 - N, N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors (2013-04-16),

15. 8349840 - Piperazine-substituted benzothiophenes for treatment of mental disorders (2013-01-08),

Title: The Innovative Journey of Shin Miyamura

Introduction: Shin Miyamura is a pioneering inventor hailing from Tokushima, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Shin Miyamura holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his continuous dedication to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Shin Miyamura has worked tirelessly to develop cutting-edge solutions that have revolutionized various industries. His innovative spirit and commitment to excellence have earned him recognition as a leading figure in the world of inventors.

Collaborations: Throughout his career, Shin Miyamura has collaborated with top research institutions, universities, and tech companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of numerous groundbreaking projects.

Conclusion: In conclusion, Shin Miyamura's passion for innovation and his relentless pursuit of technological advancement have solidified his position as a visionary inventor. His contributions have not only transformed industries but have also inspired future generations to push the boundaries of what is possible in the world of invention.

Profile summary based on public USPTO records.